Table 2.
Subsets of peripheral blood mononuclear cells after mitogen stimulation
| |
Before administration |
23 weeks after administration |
Stimulators | ||
|---|---|---|---|---|---|
| Control | Germanium biotite | Control | Germanium biotite | ||
| CD79a+ |
8.40% (±0.17) |
7.90% (±0.14) |
6.70% (±0.53) |
4.70% (±1.01) |
LPS |
| CD3+ |
59.50% (±0.49) |
57.80% (±0.53) |
93.50% (±0.04) |
93.10% (±0.28) |
ConA |
| CD4+ |
14.10% (±0.72) |
13.00% (±0.22) |
15.40% (±0.58) |
23.80% (±0.52)** |
ConA |
| CD8+ |
12.50% (±0.74) |
10.40% (±1.30) |
14.30% (±1.40) |
10.20% (±1.21) |
ConA |
| MHC Ι+, ΙΙ+ | 43.00% (±0.45) | 37.50% (±0.12) | 8.80% (±0.17) | 10.20% (±0.15)** | ConA |
The data were expressed as mean ± standard deviation (SD) (**p < 0.01 compared to the control group at each time point).